Revenue
2023
2024
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000 | 1999 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | — | $0 | $0 | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Research & development | $621,885 | $593,988 | $764,827 | $901,976 | $1.7M | $2.3M | $2.0M | $1.9M | $950,470 | $822,922 | $683,132 | $620,634 | $356,877 | $672,443 | $451,372 | — | — | — | — | — | — | — | — | — | — | — | — |
| Operating expenses | $2.4M | $2.6M | $2.3M | $3.7M | $7.9M | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Operating income | −$2.4M | −$2.6M | −$2.3M | −$3.7M | −$7.9M | −$7.6M | −$6.4M | −$5.6M | −$3.7M | −$3.1M | −$3.1M | −$3.0M | −$3.2M | −$2.3M | −$3.6M | — | — | — | — | — | — | — | — | — | — | — | — |
| EBITDAderived | −$2.3M | −$2.6M | −$2.3M | −$3.7M | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Net income | −$2.3M | −$3.5M | −$2.4M | −$4.9M | −$7.9M | −$7.4M | −$6.9M | −$6.9M | −$5.4M | −$4.6M | −$8.1M | −$3.9M | −$4.3M | −$2.4M | −$3.6M | −$233,136 | $2.0M | −$5.7M | −$1.4M | −$157,982 | −$103,142 | −$19,787 | −$97,662 | −$54,935 | −$12,904 | −$12,446 | −$77,946 |
| Basic EPSper diluted share | -$0.04 | -$0.06 | -$0.04 | -$0.09 | -$0.15 | -$0.14 | -$0.14 | -$0.19 | -$0.17 | -$0.17 | -$0.32 | -$0.16 | -$0.19 | -$0.12 | -$0.18 | — | — | — | — | — | — | — | — | — | — | — | — |
| Diluted EPSper diluted share | -$0.04 | -$0.06 | -$0.04 | -$0.09 | -$0.15 | -$0.14 | -$0.14 | -$0.19 | -$0.17 | -$0.17 | -$0.32 | -$0.16 | -$0.19 | -$0.12 | -$0.18 | — | — | — | — | — | — | — | — | — | — | — | — |